This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Dhakal, H. P. Articles by Nesland, J. M. Search for Related Content PubMed PubMed Citation Articles by Dhakal, H. P. Articles by Nesland, J. M.

Vascularization in Primary Breast Carcinomas: Its Prognostic Significance and Relationship with Tumor Cell Dissemination

Authors' Affiliations: ¹ Pathology Laboratories, ² Cancer Clinic, and ³ Surgical Clinic, Rikshospitalet-Radiumhospitalet Medical Center, University of Oslo, Montebello, Oslo, Norway, and ⁴ Surgical Department, Ullevål University Hospital, Kirkeveien, Oslo, Norway

Requests for reprints: Jahn M. Nesland, Pathology Laboratories, Rikshospitalet-Radiumhospitalet Medical Center, University of Oslo, Montebello 0310, Oslo, Norway. Phone: 47-2293-5620; Fax: 47-2273-0164; E-mail: j.m.nesland{at}medisin.uio.no.

Purpose: The interaction between tumor cells, stroma, and endothelial cells is important for the dissemination of tumor cells. The aim of the present study is to examine vascularity in primary breast carcinomas and its prognostic significance and relationship with tumor cell dissemination.

Experimental Design: A total of 498 invasive breast carcinomas were analyzed. Representative tumor sections were stained for CD34 and CD105, and vascularity was quantified by the Chalkley method. The relationship between Chalkley counts, vascular invasion, disseminated tumor cells (DTC) in the bone marrow, other clinicopathologic variables, and clinical outcome was evaluated.

Results: High vascular grades determined by Chalkley counts were significantly associated with shorter distant disease–free survival and breast cancer–specific survival in all patients (P < 0.001, log-rank) and in node-negative patients not receiving adjuvant systemic therapy (P < 0.05). In multivariate analysis, both CD34 and CD105 Chalkley counts showed prognostic significance for distant disease–free survival (P = 0.014 and P = 0.026), whereas CD34 also showed prognostic significance for breast cancer–specific survival (P = 0.007). Vascular invasion and DTCs in the bone marrow showed independent prognostic significance. DTC did not discriminate survival for CD34 low Chalkley counts, whereas a very poor prognosis was observed for DTC-positive patients with high CD34 counts. In node-negative patients not receiving systemic chemotherapy, high CD34 and high CD105 counts in combination identified patients with unfavorable outcome, as opposed to all other CD34/CD105 combinations.

Conclusions: Improved identification of risk groups could be obtained by adding CD34 and CD105 vascular analysis to DTC, vascular invasion, and other primary tumor factors. This may facilitate the selection of candidates for adjuvant systemic therapy.

This article has been cited by other articles:

				B. D. Robinson, G. L. Sica, Y.-F. Liu, T. E. Rohan, F. B. Gertler, J. S. Condeelis, and J. G. Jones Tumor Microenvironment of Metastasis in Human Breast Carcinoma: A Potential Prognostic Marker Linked to Hematogenous Dissemination Clin. Cancer Res., April 1, 2009; 15(7): 2433 - 2441. [Abstract] [Full Text] [PDF]